News
Positive Results from Phase 2 Study of MYMD-1 in Patients with Chronic Inflammation Associated with Sarcopenia
By Colin Kellaher MyMD Pharmaceuticals announced today the positive topline results from a Phase 2 study of its lead product candidate, MYMD-1. This ...
